Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

NCT02613871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: LDV/SOF

Sponsor

Gilead Sciences